Back to Search
Start Over
TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Company's Novel TRuC(TM)-T Cells
- Source :
- GlobeNewswire. May 7, 2019
- Publication Year :
- 2019
-
Abstract
- CAMBRIDGE, May 07, 2019 (GLOBE NEWSWIRE via COMTEX) -- TCR Therapeutics Inc. (TCR) (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.584603422